A detailed history of Pathstone Holdings, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 58,959 shares of LXRX stock, worth $48,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,959
Previous 60,038 1.8%
Holding current value
$48,935
Previous $100,000 8.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.51 - $2.39 $1,629 - $2,578
-1,079 Reduced 1.8%
58,959 $92,000
Q2 2024

Aug 14, 2024

SELL
$1.54 - $2.28 $4,137 - $6,126
-2,687 Reduced 4.28%
60,038 $100,000
Q1 2024

May 13, 2024

BUY
$1.3 - $3.58 $36,764 - $101,242
28,280 Added 82.1%
62,725 $150,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.53 $34,445 - $52,700
34,445 New
34,445 $52,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $157M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.